title: Rituximab in refractory and relapsed dermatomyositis and polymyositis: comment on the article by Oddis et al.
authors.affiliation: Icahn School of Medicine at Mount Sinai, New York, NY.
authors.forename: Janet
authors.initials: J
authors.lastname: Cuttner
authors.forename: Harry
authors.initials: H
authors.lastname: Spiera
authors.forename: Peter
authors.initials: P
authors.lastname: Gorevic
mesh_terms: D058846:Antibodies, Monoclonal, Murine-Derived / Q000627:therapeutic use*; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D003882:Dermatomyositis / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008297:Male; D017285:Polymyositis / Q000188:drug therapy*
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; D018501:Antirheumatic Agents